{"altmetric_id":19676160,"selected_quotes":["#Durvalumab #tremelimubab + radiation for soft-tissue #sarcoma."],"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["Vincent Ng, University of Maryland"],"first_seen_on":"2017-04-28T21:34:58+00:00","issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1505939798,"links":["https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03116529"],"nct_id":"NCT03116529","pubdate":"2017-04-12T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"Neoadjuvant Durvalumab and Tremelimumab Plus Radiation for High Risk Soft-Tissue Sarcoma (NEXIS)","type":"clinical_trial_study_record"},"altmetric_score":{"score":1,"score_history":{"1y":1,"6m":1,"3m":0.75,"1m":0.75,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1},"context_for_score":{"all":{"total_number_of_other_articles":8440508,"mean":7.0976499018281,"rank":4509728,"this_scored_higher_than_pct":27,"this_scored_higher_than":2351317,"rank_type":"exact","sample_size":8440508,"percentile":27},"similar_age_3m":{"total_number_of_other_articles":248376,"mean":12.827441868143,"rank":137882,"this_scored_higher_than_pct":35,"this_scored_higher_than":87694,"rank_type":"exact","sample_size":248376,"percentile":35},"this_journal":{"total_number_of_other_articles":24887,"mean":10.554249457526,"rank":14161,"this_scored_higher_than_pct":33,"this_scored_higher_than":8389,"rank_type":"exact","sample_size":24887,"percentile":33},"similar_age_this_journal_3m":{"total_number_of_other_articles":736,"mean":11.238081632653,"rank":445,"this_scored_higher_than_pct":30,"this_scored_higher_than":222,"rank_type":"exact","sample_size":736,"percentile":30}}},"demographics":{"poster_types":{"member_of_the_public":1,"science_communicator":1},"users":{"twitter":{"cohorts":{"Science communicators (journalists, bloggers, editors)":1,"Members of the public":1}}},"geo":{"twitter":{"US":1,"ES":1}}},"counts":{"total":{"posts_count":3},"twitter":{"unique_users_count":2,"unique_users":["SuzieSiegel","pablodesaavedra"],"posts_count":2},"facebook":{"unique_users_count":1,"unique_users":["153661297996197"],"posts_count":1}},"posts":{"facebook":[{"title":"Neoadjuvant Durvalumab and Tremelimumab Plus Radiation for High Risk Soft-Tissue Sarcoma - Full Text View - ClinicalTrials.gov","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1617140168314962&id=153661297996197","license":"public","citation_ids":[19676160],"posted_on":"2017-04-19T22:49:28+00:00","summary":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03116529","author":{"name":"Synovial Sarcoma Survivors Network","url":"https:\/\/www.facebook.com\/153661297996197","facebook_wall_name":"Synovial Sarcoma Survivors Network","image":"https:\/\/graph.facebook.com\/153661297996197\/picture","id_on_source":"153661297996197"}}],"twitter":[{"url":"http:\/\/twitter.com\/SuzieSiegel\/statuses\/910602887839002624","license":"gnip","citation_ids":[19676160],"posted_on":"2017-09-20T20:33:41+00:00","author":{"name":"Suzie Siegel","image":"https:\/\/pbs.twimg.com\/profile_images\/910167963604578309\/0OVMnNuA_normal.jpg","description":"Newspaper reporter & editor before  metastatic #leiomyosarcoma.  #Ostomate. Master's in women's studies. Former board member of #Sarcoma Alliance.","id_on_source":"SuzieSiegel","tweeter_id":"850054435","geo":{"lt":27.94752,"ln":-82.45843,"country":"US"},"followers":709},"tweet_id":"910602887839002624"},{"url":"http:\/\/twitter.com\/pablodesaavedra\/statuses\/910603630625116162","license":"gnip","rt":["SuzieSiegel"],"citation_ids":[19676160],"posted_on":"2017-09-20T20:36:38+00:00","author":{"name":"PabloAlex","image":"https:\/\/pbs.twimg.com\/profile_images\/912795809594449923\/QUvbnAya_normal.jpg","id_on_source":"pablodesaavedra","tweeter_id":"276477936","geo":{"lt":40,"ln":-4,"country":"ES"},"followers":119},"tweet_id":"910603630625116162"}]}}